1st testing group was 100% successful. 2nd testing group has issues with 2 patients. Awaiting 1st testing group results, and they look healthy with the 8.8% stake by Mallinckrodt. There was no 8K in November.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.